bar_chartACADIA Pharmaceuticals Inc.
ACAD | Healthcare | Biotechnology
bar_chartPerformance
bar_chartPerformance(Quarter)
bar_chartCash Flow
bar_chartCash Flow(Quarter)
bar_chartInstitutional Holders
Holder |
% Out |
Shares |
Baker Brothers Advisors, LLC |
26.36% |
41,904,586 |
FMR, LLC |
12.42% |
19,748,348 |
Price (T.Rowe) Associates Inc |
6.63% |
10,537,138 |
Vanguard Group, Inc. (The) |
6.52% |
10,369,690 |
Blackrock Inc. |
4.5% |
7,161,211 |
Janus Henderson Group PLC |
3.59% |
5,706,104 |
State Street Corporation |
1.7% |
2,702,584 |
Citadel Advisors LLC |
1.62% |
2,569,751 |
Shaw D.E. & Co., Inc. |
1.42% |
2,264,513 |
Pictet Asset Management Ltd |
1.41% |
2,235,863 |
bar_chartMutual Fund Holders
Holder |
% Out |
Shares |
Fidelity Growth Company Fund |
4.6% |
7,313,233 |
Vanguard Total Stock Market Index Fund |
2.1% |
3,344,091 |
Price (T.Rowe) New Horizons Fund |
2.03% |
3,233,242 |
Vanguard Small-Cap Index Fund |
1.84% |
2,924,253 |
Price (T.Rowe) Health Sciences Fund |
1.54% |
2,441,459 |
Vanguard Small-Cap Growth Index Fund |
1.12% |
1,776,835 |
Vanguard Extended Market Index Fund |
1.02% |
1,623,447 |
Janus Henderson Triton Fund |
1.01% |
1,607,769 |
Fidelity Series Growth Company Fund |
0.99% |
1,573,671 |
iShares NASDAQ Biotechnology ETF |
0.94% |
1,499,216 |